Biden says Brittney Griner is ‘safe’ after release from Russia in prisoner swap

Yahoo! News

Biden says Brittney Griner is ‘safe’ after release from Russia in prisoner swap

Dylan Stableford, Senior Writer – December 8, 2022

President Biden on Thursday said Brittney Griner is “safe” and on her way home after being freed from Russian custody in a prisoner exchange for convicted arms dealer Viktor Bout.

“She’s safe, she’s on a plane, she’s on her way home,” Biden said in brief remarks at the White House, where he was joined by Griner’s wife, Cherelle, Vice President Kamala Harris and Secretary of State Antony Blinken. “After months of being detained in Russia, held under intolerable circumstances, Brittney will soon be back in the arms of her loved ones, and she should’ve been there all along.”

Biden said he spoke with Griner and that she is in “good spirits.”

President Joe Biden speaks in the Roosevelt Room of the White House
President Biden speaks to reporters about the release of WNBA basketball star Brittney Griner on Thursday. (Patrick Semansky/AP)

“The fact remains that she’s lost months of her life, experienced needless trauma,” he said. “She deserves space, privacy and time with her loved ones to recover and heal from her time being wrongfully detained.”

Griner has been held in Russia since February, when she was detained in Moscow after being found carrying vape cartridges containing cannabis oil in her luggage. She pleaded guilty and was sentenced to nine years in prison.

“This is a day we’ve worked toward for a long time,” Biden said. “We never stopped pushing for her release. It took painstakingly intense negotiations.”

Brittney Griner is escorted from a courtroom after a hearing in Khimki just outside Moscow.
Biden said Griner was “unjustly detained” in Russia before she was released in a prisoner swap with Russian arms dealer Viktor Bout. (Alexander Zemlianichenko, File/AP)

The president thanked those in his administration who worked to secure her release as well as the United Arab Emirates, where a plane transporting Griner back to the United States landed.

“These past few months have been hell for Brittney and Cherelle and her entire family,” Biden said. “People across the country have learned about Brittney’s story, advocated for her release throughout this terrible ordeal. And I know that support meant a lot to her family.”

The president also said the U.S. has not given up on Paul Whelan, a Michigan corporate security executive who has been jailed in Russia since 2018 on espionage charges.

“We did not forget about Brittney, and we have not forgotten about Paul Whelan, who has been unjustly detained in Russia for years,” Biden said. “This was not a choice of which American to bring home.”

President Biden and Cherelle Griner speak on the phone with WNBA basketball star Brittney Griner after her release by Russia, in this White House handout photo taken in the Oval Office, as Vice President Kamala Harris and Secretary of State Antony Blinken look on.
The White House released this image of Biden and Griner’s wife, Cherelle, speaking to the WNBA star after she was released from Russia. (The White House/Handout via Reuters)

Biden pointed to Trevor Reed, a 30-year-old U.S. Marine veteran who was released in a prisoner swap with Russia in April.

“We brought home Trevor Reed when we had a chance earlier this year,” the president said. “Sadly, for illegitimate reasons, Russia is treating Paul’s case differently than Brittney’s. And while we have not yet succeeded in securing Paul’s release, we are not giving up. We will never give up.”

In a statement, the Whelan family said the Biden administration “made the right decision” in securing Griner’s release and “to make the deal that was possible, rather than waiting for one that wasn’t going to [happen].”

In brief remarks, Cherelle Griner thanked Biden for helping secure Brittney’s release.

“Today my family is whole,” Cherelle Griner said. “But as you all are aware, there’s so many other families who are not whole.”

She added: “Brittney and I will remain committed to the work of getting every American home, including Paul, whose family is in our hearts today.”

Nearly half of COVID patients worldwide still have symptoms after 4 months, according to a giant new study

Fortune

Nearly half of COVID patients worldwide still have symptoms after 4 months, according to a giant new study

Erin Prater – December 7, 2022

Almost half of COVID survivors globally—both children and adults—have lingering symptoms four months later, according to a landmark new study.

Researchers at the University of Leicester in England performed an analysis of nearly 200 studies of prior COVID patients, involving nearly 750,000 people in all. The patients—some of whom were hospitalized and some of whom weren’t—lived across the globe.

More than 45% of study participants had at least one lingering symptom four months out from their initial infection. A quarter of the patients reported fatigue, and a similar number said they felt pain or discomfort. Meanwhile, sleep issues, breathlessness, and problems participating in normal daily activities were reported in just under a quarter of patients, according to the study.

Often, no clinical abnormalities could be found to explain such symptoms. But some signs were reported in many patients who had been hospitalized with COVID, including changes in lung structure and function. An abnormal CT scan and/or X-rays were found in nearly half of previously hospitalized patients, in addition to a decreased capacity to diffuse carbon monoxide in nearly a third of patients.

“Changes in pulmonary function are similar to those observed following other viral infections including SARS and MERS,” the authors wrote.

When nonhospitalized COVID survivors were singled out, more than a third of them had lingering symptoms at four months, the study found.

“The reasons as to why so many patients are experiencing long COVID remains unknown,” the authors wrote, adding that possible causes include organ damage, inflammation, altered immune systems, and psychological effects.

While some studies have found a higher rate of long COVID in females, the study out of Leicester didn’t find that any particular age group or gender experienced higher rates of the disabling condition. Researchers weren’t able to reliably assess any potential association with race, as only a quarter of studies examined provided participants’ race or ethnicity.

Nearly 20% of American adults who’ve had COVID—an estimated 50 million—report having long COVID symptoms, according to data collected by the U.S. Census Bureau this summer.

Long COVID is roughly defined as symptoms that persist or appear long after the initial infection is gone, but a consensus definition has not yet been broadly accepted. Many experts contend that long COVID is best defined as a chronic-fatigue-syndrome–like condition that develops after COVID illness, similar to other post-viral syndromes that can occur after infection with herpes, Lyme disease, and even Ebola. Other post-COVID complications, like organ damage and post–intensive-care syndrome, should not be defined as long COVID, they say.

Vitamin D could prevent Alzheimer’s, new research reveals

Independent

Vitamin D could prevent Alzheimer’s, new research reveals

Mark Waghorn – December 7, 2022

Vitamin D (Copyright 2016 The Associated Press. All rights reserved.)
Vitamin D (Copyright 2016 The Associated Press. All rights reserved.)

Vitamin D pills could stave off Alzheimer’s disease, according to new research.

Brains of older people with higher levels of the nutrient function better, say nutritionists.

The main natural source is sunlight but wrinkly skin is less efficient at converting it, meaning older individuals are more likely to be deficient.

Corresponding author Dr Sarah Booth said: “This research reinforces the importance of studying how food and nutrients create resilience to protect the ageing brain against diseases such as Alzheimer’s and other related dementias.”

The number of cases worldwide will triple to more than 150 million by 2050. And with no cure in sight, there is an increasing focus on preventive measures such as lifestyle.

Dr Booth and colleagues examined post mortem samples of brain tissue from 209 participants in the Rush Memory and Ageing Project that began in 1997.

It is the first analysis of its kind, comparing vitamin D levels in adults who suffered from varying rates of cognitive decline.

Lead author Professor Kyla Shea said: “Many studies have implicated dietary or nutritional factors in cognitive performance or function in older adults, including many studies of vitamin D, but all of them are based on either dietary intakes or blood measures of vitamin D.

“We wanted to know if vitamin D is even present in the brain, and if it is, how those concentrations are linked to cognitive decline.”

The team at Tufts University in Massachusetts found more vitamin D in all four regions looked at correlated with better mental skills.

Two areas are associated with changes linked to Alzheimer’s, one with dementias due to to blood flow and the other without any associations with brain or vascular diseases.

Participants’ cognitive function was assessed at the outset and as they aged – with irregularities in their brain tissue identified after death.

No connection was found between vitamin D levels and any of the physiological markers associated with Alzheimer’s disease.

These included rogue amyloid beta proteins that gather in plaques, Lewy body disease or chronic or microscopic strokes.

This means it is still unclear exactly how vitamin D might affect brain function.

Prof Shea said: “Dementia is multifactorial, and lots of the pathological mechanisms underlying it have not been well characterised.

“Vitamin D could be related to outcomes that we didn’t look at yet, but plan to study in the future.”

Vitamin D is also known to vary between racial and ethnic populations, and most of the participants in the original cohort were white

The researchers are planning followup studies using a more diverse group of subjects to look at other brain changes associated with cognitive decline.

They hope their work leads to a better understanding of the role vitamin D may play in staving off dementia.

Experts caution people not to use large doses of vitamin D supplements as a preventive measure.

The recommended dose of vitamin D is 600 IU (international units) for under 70s and 800 for those older.

Excessive amounts can cause harm, and have been linked to the risk of falling.

Prof Shea said: “We now know that vitamin D is present in reasonable amounts in human brains, and it seems to be correlated with less decline in cognitive function.

“But we need to do more research to identify the neuropathology that vitamin D is linked to in the brain before we start designing future interventions.”

The study was published in the journal Alzheimer’s & Dementia.

Harnessing the brain’s immune cells to stave off Alzheimer’s and other neurodegenerative diseases

The Conversation

Harnessing the brain’s immune cells to stave off Alzheimer’s and other neurodegenerative diseases

Kristine Zengeler, University of Virginia – December 7, 2022

Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to neurodegeneration, which may not be effective in completely addressing disease symptoms or progress, if at all.

But what if researchers harnessed the brain’s inherent capabilities to cleanse and heal itself? My colleagues and I in the Lukens Lab at the University of Virginia believe that the brain’s own immune system may hold the key to neurodegenerative disease treatment. In our research, we found a protein that could possibly be leveraged to help the brain’s immune cells, or microglia, stave off Alzheimer’s disease.

Challenges in treating neurodegeneration

No available treatments for neurodegenerative diseases stop ongoing neurodegeneration while also helping affected areas in the body heal and recuperate.

In terms of failed treatments, Alzheimer’s disease is perhaps the most infamous of neurodegenerative diseases. Affecting more than 1 in 9 U.S. adults 65 and older, Alzheimer’s results from brain atrophy with the death of neurons and loss of the connections between them. These casualties contribute to memory and cognitive decline. Billions of dollars have been funneled into researching treatments for Alzheimer’s, but nearly every drug tested to date has failed in clinical trials.

Another common neurodegenerative disease in need of improved treatment options is multiple sclerosis. This autoimmune condition is caused by immune cells attacking the protective cover on neurons, known as myelin. Degrading myelin leads to communication difficulties between neurons and their connections with the rest of the body. Current treatments suppress the immune system and can have potentially debilitating side effects. Many of these treatment options fail to address the toxic effects of the myelin debris that accumulate in the nervous system, which can kill cells.

A new frontier in treating neurodegeneration

Microglia are immune cells masquerading as brain cells. In mice, microglia originate in the yolk sac of an embryo and then infiltrate the brain early in development. The origins and migration of microglia in people are still under study.

Microglia play important roles in healthy brain function. Like other immune cells, microglia respond rapidly to pathogens and damage. They help to clear injuries and mend afflicted tissue, and can also take an active role in fighting pathogens. Microglia can also regulate brain inflammation, a normal part of the immune response that can cause swelling and damage if left unchecked.

Microglia also support the health of other brain cells. For instance, they can release molecules that promote resilience, such as the protein BDNF, which is known to be beneficial for neuron survival and function.

But the keystone feature of microglia are their astounding janitorial skills. Of all brain cell types, microglia possess an exquisite ability to clean up gunk in the brain, including the damaged myelin in multiple sclerosis, pieces of dead cells and amyloid beta, a toxic protein that is a hallmark of Alzheimer’s. They accomplish this by consuming and breaking down debris in their environment, effectively eating up the garbage surrounding them and their neighboring cells.

Given the many essential roles microglia serve to maintain brain function, these cells may possess the capacity to address multiple arms of neurodegeneration-related dysfunction. Moreover, as lifelong residents of the brain, microglia are already educated in the best practices of brain protection. These factors put microglia in the perfect position for researchers to leverage their inherent abilities to protect against neurodegeneration.

New data in both animal models and human patients points to a previously underappreciated role microglia also play in the development of neurodegenerative disease. Many genetic risk factors for diseases like Alzheimer’s and multiple sclerosis are strongly linked to abnormal microglia function. These findings support an accumulating number of animal studies suggesting that disruptions to microglial function may contribute to neurologic disease onset and severity.

This raises the next logical question: How can researchers harness microglia to protect the nervous system against neurodegeneration?

Engaging the magic of microglia

In our lab’s recent study, we keyed in on a crucial protein called SYK that microglia use to manipulate their response to neurodegeneration.

Our collaborators found that microglia dial up the activity of SYK when they encounter debris in their environment, such as amyloid beta in Alzheimer’s or myelin debris in multiple sclerosis. When we inhibited SYK function in microglia, we found that twice as much amyloid beta accumulated in Alzheimer’s mouse models and six times as much myelin debris in multiple sclerosis mouse models.

Blocking SYK function in the microglia of Alzheimer’s mouse models also worsened neuronal health, indicated by increasing levels of toxic neuronal proteins and a surge in the number of dying neurons. This correlated with hastened cognitive decline, as the mice failed to learn a spatial memory test. Similarly, impairing SYK in multiple sclerosis mouse models exacerbated motor dysfunction and hindered myelin repair. These findings indicate that microglia use SYK to protect the brain from neurodegeneration.

But how does SYK protect the nervous system against damage and degeneration? We found that microglia use SYK to migrate toward debris in the brain. It also helps microglia remove and destroy this debris by stimulating other proteins involved in cleanup processes. These jobs support the idea that SYK helps microglia protect the brain by charging them to remove toxic materials.

Finally, we wanted to figure out if we could leverage SYK to create “super microglia” that could help clean up debris before it makes neurodegeneration worse. When we gave mice a drug that boosted SYK function, we found that Alzheimer’s mouse models had lower levels of plaque accumulation in their brains one week after receiving the drug. This finding points to the potential of increasing microglia activity to treat Alzheimer’s disease.

Of the many brain cells (shown in black), giving microglia a boost could help them more effectively clean up debris in the brain. <a href=
Of the many brain cells (shown in black), giving microglia a boost could help them more effectively clean up debris in the brain. Jose Luis Calvo Martin & Jose Enrique Garcia-Mauriño Muzquiz/iStock via Getty Images Plus
The horizon of microglia treatments

Future studies will be necessary to see whether creating a super microglia cleanup crew to treat neurodegenerative diseases is beneficial in people. But our results suggest that microglia already play a key role in preventing neurodegenerative diseases by helping to remove toxic waste in the nervous system and promoting the healing of damaged areas.

It’s possible to have too much of a good thing, though. Excessive inflammation driven by microglia could make neurologic disease worse. We believe that equipping microglia with the proper instructions to carry out their beneficial functions without causing further damage could one day help treat and prevent neurodegenerative disease.

Listen to The Conversation’s podcast series Uncharted Brain: Decoding Dementia to find out more about the latest research unlocking clues to the ongoing mystery of how dementia works in the brain. Find all episodes via The Anthill podcast.

Nearly half of COVID patients worldwide still have symptoms after 4 months

Fortune

Nearly half of COVID patients worldwide still have symptoms after 4 months, according to a giant new study

Erin Prater – December 7, 2022

Hyoung Chang—The Denver Post/Getty Images

Almost half of COVID survivors globally—both children and adults—have lingering symptoms four months later, according to a landmark new study.

Researchers at the University of Leicester in England performed an analysis of nearly 200 studies of prior COVID patients, involving nearly 750,000 people in all. The patients—some of whom were hospitalized and some of whom weren’t—lived across the globe.

More than 45% of study participants had at least one lingering symptom four months out from their initial infection. A quarter of the patients reported fatigue, and a similar number said they felt pain or discomfort. Meanwhile, sleep issues, breathlessness, and problems participating in normal daily activities were reported in just under a quarter of patients, according to the study.

Often, no clinical abnormalities could be found to explain such symptoms. But some signs were reported in many patients who had been hospitalized with COVID, including changes in lung structure and function. An abnormal CT scan and/or X-rays were found in nearly half of previously hospitalized patients, in addition to a decreased capacity to diffuse carbon monoxide in nearly a third of patients.

“Changes in pulmonary function are similar to those observed following other viral infections including SARS and MERS,” the authors wrote.

When nonhospitalized COVID survivors were singled out, more than a third of them had lingering symptoms at four months, the study found.

“The reasons as to why so many patients are experiencing long COVID remains unknown,” the authors wrote, adding that possible causes include organ damage, inflammation, altered immune systems, and psychological effects.

While some studies have found a higher rate of long COVID in females, the study out of Leicester didn’t find that any particular age group or gender experienced higher rates of the disabling condition. Researchers weren’t able to reliably assess any potential association with race, as only a quarter of studies examined provided participants’ race or ethnicity.

Nearly 20% of American adults who’ve had COVID—an estimated 50 million—report having long COVID symptoms, according to data collected by the U.S. Census Bureau this summer.

Long COVID is roughly defined as symptoms that persist or appear long after the initial infection is gone, but a consensus definition has not yet been broadly accepted. Many experts contend that long COVID is best defined as a chronic-fatigue-syndrome–like condition that develops after COVID illness, similar to other post-viral syndromes that can occur after infection with herpes, Lyme disease, and even Ebola. Other post-COVID complications, like organ damage and post–intensive-care syndrome, should not be defined as long COVID, they say.

US sees worst flu outbreak in 10 years: Which states are being hit hardest by ‘tripledemic’?

Today
US sees worst flu outbreak in 10 years: Which states are being hit hardest by ‘tripledemic’?

Linda Carroll – December 6, 2022

Fears of a “tripledemic” in the U.S. seem to be coming to true, as flu hospitalizations hit their highest level in a decade, COVID cases rise following Thanksgiving gatherings, and respiratory syncytial virus (RSV) continues to sicken children across the country.

“This year’s flu season is off to a rough start,” Dr. Sandra Fryhofer, board chair of the American Medical Association, said at a Dec. 5 press briefing hosted by the Centers for Disease Control and Prevention. “Flu is here. It started early, and with COVID and RSV also circulating, it’s a perfect storm for a terrible holiday season.”

While cases of RSV, which have been straining children’s hospitals since the early fall, may have peaked in some parts of the country, flu activity is surging ahead of schedule, CDC director Dr. Rochelle Walensky said at the briefing. And the number of new COVID-19 cases per day has increased 16% over the past two weeks, according to NBC News’ tally.

Inpatient hospital beds in the U.S. are currently about 78% full, per data from the Department of Health and Human Services. Ten states are reporting their pediatric hospital beds are 90% full or higher, according to an NBC News analysis.

The continued shortage of health workers is also making this winter a difficult one for illnesses. Even prior to the pandemic, there were already too few health workers to go around, but it’s gotten worse in the years since. In fact, TODAY.com previously reported that some hospitals have beds available but no staff to care for those patients.

What is a tripledemic?

The tripledemic of 2022 refers to the possibility that COVID-19, seasonal influenza and RSV will all surge at the same time. COVID-19 and the flu are certainly on the upswing, but RSV may be slowing down, per CDC data. That said, all three viruses are still continuing to cause widespread illness.

In early October, cases of respiratory viruses, including RSV, were already causing many children’s hospitals to reach capacity, with one facility in Connecticut reporting its worst RSV surge in 25 years, TODAY.com previously reported. Data from the Centers for Disease Control and Prevention show that RSV hospitalization rates are much higher this year than in the past, but are starting to decline.

Related: Where are kids most likely to get RSV?

The number of positive RSV tests in the U.S. fell from over 19,000 the week ending Nov. 12 to 7,500 the week ending Nov. 26, per CDC data. At the Dec. 5 briefing, Walensky said RSV cases have peaked in the South and Southeast and plateaued in the Mid-Atlantic, New England and Midwest. It’s not clear if the trend will hold, however.

“RSV is usually seen in January and February,” Dr. Roberto Posada, a professor of pediatrics at Mount Sinai Kravis Children’s Hospital in New York City, tells TODAY.com. “We hadn’t seen that much in the way of RSV and even influenza over the past two years, and that may be because of masking and people not getting together.” Because of that, people have less immunity at a time when they are gathering more and masking less, Posada explains.

Influenza is also on the rise, with the U.S. seeing the highest number of hospitalizations for this time of year in a decade, NBC News reported. Roughly 78,000 people have been hospitalized with flu and 4,500 have died since early October, NBC News reported. The number of flu hospitalizations in the U.S. doubled from the second-to-last week in November to the last. Since Oct. 1, the flu has caused 8.7 million illnesses; for context, 9 million illnesses were reported for the entire 2021-2022 flu season.

And third, putting the “triple” in “tripledemic,” is the steady increase in COVID-19 cases since the Thanksgiving holiday. In addition to the increase in daily new cases recorded by the NBC News tally, daily COVID-related hospital admissions increased 18% from the week ending Nov. 22 to the week ending Nov. 29, per CDC data. Experts previously told TODAY.com that it’s likely cases will continue to increase as people gather for Christmas and New Year’s and spend more time indoors as temperatures drop.

“If you add an omicron surge to the current RSV surge, there’s no place … to put another 50 kids that need to be admitted to the hospital,” Dr. Jason Newland, professor of pediatric infectious diseases at Washington University School of Medicine in St. Louis, tells TODAY.com.

Even though flu and RSV may be a bit early, it’s typical in winter to see a surge of these viruses, Dr. Michael Angarone, associate professor of infectious diseases at Northwestern Medicine in Chicago, tells TODAY.com. But this year is likely to be different: “What we are worried about is having the typical cold and flu seasons combined with SARS-CoV-2,” he says.

The real fear around a tripledemic is the possibility that the three viruses will peak at the same time and inundate hospitals, filling every bed and stretching staff thin, Posada adds.

What parts of the U.S. are highest risk for a tripledemic in 2022?

RSV, COVID-19 and flu are more likely to have a severe impact on parts of the country that are colder, Dr. David Buchholz, a pediatrician and founding medical director of primary care at Columbia University in New York City, tells TODAY.com.

When the air is frigid, people are more likely to huddle indoors and keep their windows closed, which makes transmission of the viruses more likely, Buchholz says. “Where it’s warmer, people are more likely to spend time outdoors and open their windows,” he adds.

Another factor pumping up the spread of these three bugs in cold climates is the viruses’ affinity for cool, dry air, Dr. Timothy Brewer, professor of medicine and epidemiology at University of California, Los Angeles, tells TODAY.com. In fact, this phenomenon may explain the burst of flu activity in Texas and the Southeast in early November, which experienced a cold snap right before, he says.

As of the week ending in Nov. 26, all but five states are experiencing “high” or “very high” flu activity, the CDC reported. Based on the CDC’s flu activity ranking by level, New Hampshire is the only state at level 1 (also called “minimal”), and 11 states are at the highest level recorded so far, 13. These are:

  • California
  • Colorado
  • Kentucky
  • Nebraska
  • New Mexico
  • Ohio
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington

Brewer also says the parts of the U.S. with the lowest vaccination rates against COVID-19 and flu “will most likely get into trouble with these viruses,” he said. (There’s no vaccine against RSV.)

Many of the Mountain and Southern states have low vaccination rates against COVID-19, per CDC data; in 15 states, including Idaho, Alabama, South Carolina, Wyoming, Tennessee and Mississippi, less than 60% of the eligible population completed the primary series, which is approved for everyone 6 months and older.

Only about 13% of the population has received the updated booster shot targeting the omicron variant, approved for people 5 and up. All COVID-19 variants circulating right now come from omicron. The CDC announced Nov. 22 that the updated booster is more effective at preventing symptomatic COVID infections in the real world than earlier doses. White House COVID-19 response coordinator Dr. Ashish Jha called it “the best protection for this winter.”

Flu shot distribution is also lagging across the country. As of the week ending Nov. 26, the immunization rate is lower than at the same point in the previous two seasons. These states had the lowest flu vaccination rates during last year’s season, according to data from the Kaiser Family Foundation:

  • Mississippi
  • Wyoming
  • Nevada
  • Idaho
  • Florida
How to protect yourself during a tripledemic

The best way for people to protect themselves amid the possibility of a tripledemic is to get the latest COVID-19 booster and a flu shot, Angarone says. So far, it looks like the flu vaccine this year is a good match to the strains of influenza virus currently circulating, Brewer adds. There’s no vaccine for RSV, but one could be on the horizon.

Even though most people will not experience severe symptoms with RSV and the flu, “we have to be aware of others when we are sick,” Angarone says. “Even though it’s not COVID-19, you probably should not go to work and get your colleagues sick. You should make sure you are washing your hands.”

Some experts have also continued to recommend masking and opening windows at indoor, crowded events, as well as taking a rapid COVID test before holiday gatherings.

For parents of young or immunocompromised children, it’s also important to know the signs of a severe RSV infection and when to seek medical care, TODAY previously reported. These are:

  • Having trouble breathing, such as the skin around the ribs sucking in or the nostrils flaring when the child tries to breathe.
  • Grunting in babies, or difficulty speaking in older kids.
  • Diminished number of wet diapers and other signs of dehydration.
  • Increased or persistent lethargy, such as a child being difficult to wake.
  • Any sign of blue around the lips.
  • Irritability, such as crying that won’t stop.

The good news is RSV and influenza aren’t new, so we know how to prevent and treat them, and there are vaccines available to protect against two of the three viruses that contributing to the tripledemic.

Forget diets: This is how to lose weight and keep it off for good

Today

Forget diets: This is how to lose weight and keep it off for good

Kristin Kirkpatrick – December 6, 2022

Losing weight is notoriously difficult. And as hard as it is to get the scale to tick down, it’s even harder to keep the weight off. Unfortunately, recent studies show that most of us will put weight back on in two years. By five years, almost all of it may come back. Further, many people end up gaining more weight than they lost.

But keeping your focus on the end goal — better health and longevity — may increase your odds more than any extreme diet and fitness regime. In fact, the path to maintaining a healthy weight starts long before you get close to your goal weight. Here are some evidence-based ways to approach weight loss and maintenance in a healthy way.

Don’t fixate on the number on the scale

When I see patients for the first time, we discuss their health goals. The truth is that most people are aiming for a particular number. “I want to lose this many pounds,” or “I want to reach this number on the scale.” But fixating on a goal weight may work against a lot of us. Studies show that focusing on the numbers that speak to overall health may be more impactful in sustained behavior change. So, throw out the scale and focus on your lipid panel, your blood-sugar numbers, or perhaps even your inflammation markers.

Paying attention to health, rather than weight can shift the reason why you want to drop pounds in the first place. Other quality of life parameters — like better sleep, less chronic pain or increased energy —can all be major motivation for changing your habits. Finally, if you must rely on a scale, choose an option that assess body fat and muscle mass.

Learn from weight maintenance warriors 

Multiple studies have tried to demystify why one person succeeds at weight loss while another doesn’t. Two studies in the journal Obesity surveyed almost 6,000 individuals who had participated in a structured weight-loss program. The surveyed participants lost on average 50 pounds and kept their weight off for three years or more.

Based these studies, as well as previous data, people who were successful at losing weight and keeping it off did these things:

  • Made healthy food choices most of the time — and found that these choices effortless and “unconscious.”
  • Self-monitored and journaled about their food intake.
  • Consumed lower calorie, yet higher nutrient dense foods.
  • Engaged higher levels of physical activity.
  • Made continued goal setting a priority.
  • Celebrated their past achievements and embraced their current health.

Another crucial component of weight loss success was mindset — especially in the face of challenges and adversity. While both health and appearance were significant motivating factors, greater confidence and being more mentally and physically fit topped the list for being able to maintain healthy habits.

Move more

Exercise, as it turns out, is not the secret weapon to successful weight loss. When it comes to weight loss, your diet has been found to play a much more significant role in terms of pounds lost. However, when it comes to keeping those pounds from coming back, you need to move more.

A recent study from the University of Colorado found that when individuals engaged in physical activity, they maintained more steps per day (about 12,000) and maintained a higher energy expenditure. Another study published in the Archives of Internal Medicine found that in order to maintain weight loss, women needed to exercise at least 55 minutes, five days per week. This recommendation surpasses the current guidelines for exercise, which calls for only 150 minutes of moderate physical activity throughout the week and two days of muscle-building training.

Adding protein to each meal — like enjoying an egg white omelet for breakfast — has been shown to help maintain weight loss. (Sergio Amiti / Getty Images)
Adding protein to each meal — like enjoying an egg white omelet for breakfast — has been shown to help maintain weight loss. (Sergio Amiti / Getty Images)
Fall in love with protein

2020 study in the Journal of Nutrition found that high-protein diets were associated with greater success in maintaining weight loss. The study showed that having more protein often counteracted the process of adaptive thermogenesis — a state where the body adapts to a new weight by altering energy expenditure. An easy way to up your protein intake is to add some kind of protein to every meal and snack. For example, consuming eggs whites at breakfast, hummus for a snack and wild salmon for dinner.

Assess your social circle

If you’ve ever had a friend tell you that “one bite of something won’t kill you,” you know that your loved ones can have a major influence on your health habits. A study from The University of North Carolina found that individuals that lose weight may face a “lean stigma” where friends and family consciously or unconsciously sabotage or undermine efforts of the successful weight loss.

Researchers found that effective communication techniques were one way to mitigate comments and discouraging attitudes from friends and family. For example, telling loved ones ahead of time your motivation to lose weight or communicating weight-loss efforts as a way to obtain better health — and not better appearance — is a good way to let your loved ones know why your health goals are important to you.

Accept the fact that there’s no magic weight loss fix

“Unfortunately, there’s no magic bullet to lose weight quickly and sustainably,” Samantha Cassetty, a registered dietitian and author of “Sugar Shock,” told TODAY.com. “Some people like the idea of a jump-start plan, which may involve fewer calories or carbs as you’re starting out. If that helps you feel motivated and get in the right mindset to form lasting habits, go for it. But for permanent weight loss, be realistic about what you can sustain,” Cassetty explained.

Also, Cassetty added, it’s important to keep in mind that when you fast weight loss, you might overlook behaviors that need to be addressed — such as nighttime snacking or eating when you’re bored. Cassetty said that a jump-start plan probably doesn’t include your favorite foods, but it’s much more realistic to learn how to live with indulgences than to try to avoid them forever. “Overly restricting less healthy foods can be stressful, which can stall weight loss efforts,” said Cassetty.

Embrace your body — and adapt to it when it changes

Studies indicate that frequent attempts to lose and then regain weight (often referred to as yo-yo dieting) can have an adverse impact on health and lead to an increased risk of further weight gain. A 2016 study showed that repeated dieting could cause the brain to think it’s going through periods of famine. In response, the body continues to work toward fat storage to prepare for the next round. The body adapts and becomes efficient at the current lower weight, and if you don’t adapt with it, you will most likely gain the weight back.

Imagine putting on a 20-pound vest and taking a walk around the block. The walk would be challenging, and you may have to work harder during the activity. Exertion is higher, and with it so are the calories you are burning as well. Now imagine taking the vest off. The body does not have to work that hard anymore to get you around the block. If you’ve lost 50 pounds, and changed nothing in your physical activity or eating habits, you are more likely to gain that weight back. Your metabolism works with the new weight, so constant adaptation is essential.

Let go of the idea that you can target belly fat

There’s a lot of trending advice about how to lose belly fat, but the truth is that it’s difficult to target weight loss. “If you lose weight, you will lose fat in your midsection, but it’s impossible to target belly fat,”Cassetty told TODAY. However, belly fat tends to respond well to modifications in your diet and activity, Cassetty explained. “And there’s evidence that when your waist shrinks, cholesterol and blood sugar levels improve,” she said.

If you experience, belly-specific health issues, you may need to address those. “If your belly seems bigger after you eat and you experience painful bloating, it could be a sign of a food sensitivity or gut health problem,” Cassettty said. “If this is the case, consult with your healthcare provider to determine the cause and treatment plan.”

Take a break from dieting

If your idea of weight loss and weight maintenance is a “diet,” then studies show you are likely bound for failure. A 2017 randomized controlled trial found that individuals that took breaks from dieting were more likely to lose weight and keep it off. The cornerstone of dieting is often restriction. The more restricted, the less we lose. So, take a break from diets and embrace lifestyle changes instead.

Weight loss — especially when the reduction occurs in the midsection — can have a significant impact on health and longevity, though. When you focus on longevity, happiness and increased energy, your reasons for losing the weight in the first place will be clear and your ability to maintain better health will be easier.

Teen Marijuana Poisonings Have Skyrocketed. How to Keep Your Child Safe

Time

Teen Marijuana Poisonings Have Skyrocketed. How to Keep Your Child Safe

Tara Law – December 5, 2022

cannabis joint
cannabis joint

Marijuana joint Credit – Tunatura—Getty Images/iStockphoto

Cannabis might still be banned federally, but most U.S. adults (88%) say it should be legal, according to a Nov. 22 Pew Research Center poll—and in nearly half of states, it is. Like any psychoactive substance, however, cannabis comes with some health risks, especially for children and adolescents.

Over the last two decades, cannabis cases have flooded hotlines U.S. Poison Control Centers—facilities across the country staffed by toxicology experts who provide 24-hour-a-day guidance to both the general public and health professionals. According to a new study published in Clinical Toxicology on Dec. 5, which reviewed records of nearly 339,000 poison control cases, the number of calls involving marijuana rose 245% among 6- to 18-year-olds between 2000 and 2020. Over 80% of exposures were among adolescents 13 to 18.

The study did not describe the health issues caused by or associated with cannabis in these cases, but physicians who work with children say they can be serious, including episodes of psychosis. Other problems associated with cannabis are less dramatic, but also concerning, including memory problems, worsened mood problems, and trouble in school.

Why were more cases involving children and cannabis reported?

Cannabis cases rose by about 25% between 2010 and 2017, but jumped 40% between 2017 and 2020. This period coincided with the legalization of cannabis in many U.S. states, notes Dr. Adrienne Hughes, an assistant professor of emergency medicine at Oregon Health and Science University and the lead author of the paper. In that time frame, Michigan, Illinois, Arizona, and 10 other states all legalized recreational or medical marijuana use. “Obviously, it’s only legal for adults, and not children, but I think that we can probably agree that it has rendered the drug more accessible to children, and probably contributing to the perception that it’s safe as well,” says Hughes.

Another problem is that over the last few years, young people have increasingly used cannabis in newer forms, including in vapes and as edibles, the authors note. Edibles, in particular, have become more common among calls to Poison Control Centers, even though studies have shown that teens believe they’re less harmful than the traditional method of smoking marijuana, but edibles pose their own set of risks. It can be difficult to manage your dose when consuming edibles, and they may take hours to kick in—which means that kids may unwittingly eat more to try and feel their effects.

What are the risks of cannabis for kids?

Marijuana is safer than many other illicit substances like cocaine or opioids, but that is not to say that it is 100% safe. Research suggests that kids may face greater mental health risks like worsened depression and anxiety, poor attention and memory problems, and cannabis use disorder than adults, as their brains are still developing.

In some cases, cannabis can even land children in the hospital. Dr. Willough Jenkins, a psychiatrist at Rady Children’s Hospital-San Diego, the largest children’s hospital in California, says that she’s seen a dramatic increase in the number of older children being hospitalized after consuming cannabis in the last five years. She now sees several adolescent patients a week with cannabis hyperemesis syndrome, a condition involving severe vomiting which is caused by prolonged exposure to cannabis, which puts people at risk of weight loss, dehydration, and malnourishment. Patients are typically treated with IV fluids or, in some extreme cases, feeding tubes.

Jenkins also sees two or three cases a month in which cannabis use appears to have triggered a psychotic episode. “You have a youth coming into the hospital very confused, usually very disoriented, not knowing where they’re at, hallucinating,” she says. “These youth come in not able to feed themselves, not being able to get to the bathroom.”

How should I talk to my child about cannabis?

Building trust with your kids and creating a “sense of safety” is essential, says Emily Jenkins, who researches youth substance use and is an associate professor in the School of Nursing at the University of British Columbia in Canada (and is not related to Dr. Willough Jenkins). Ideally, you can avoid a specific, serious talk about it, as that could very well make a teenager shut down to anything you’re saying— it’s better to bring up these conversations more frequently and in a more casual way, such as when marijuana is mentioned in a television show.

“We can create a space that’s open, and where young people feel safe to be able to disclose their substance use or cannabis use decision making considerations and practices,” she says. If parents are too harsh when they talk about cannabis, or, on the flip side, if they are too permissive, children may be left with “nowhere to turn when they need advice or guidance,” she says.

How can I help my child to make their cannabis use safer?

Emily Jenkins notes that Canada, where she lives and which has legalized cannabis, offers a list of guidelines designed to make consuming cannabis safer. In particular, she says, parents should recognize that the greatest risks come when kids are younger—under 16, per the Canadian guidelines—and using cannabis too frequently (daily or almost every day). Jenkins adds that choosing cannabis products with a lower THC content (experts often classify a THC level of 15% or more as high potency) as well as avoiding smoking to avoid breathing in carcinogens, can also help.

Dr. Willough Jenkins, the California psychiatrist, says she sometimes works with adolescent patients to adopt healthier ways of smoking, such as reducing the amount they consume or the amount of time they spend using cannabis. Some children are also using marijuana as a way to cope with mental health challenges, such as depression or anxiety, and may need help to address their underlying condition. Experts generally agree that parents should watch for red flags to show their child’s cannabis use is getting out of control, such as missing school or showing up intoxicated; excessive coughing; or acting paranoid. It’s also essential that some teens don’t use cannabis at all—including children with conditions like cystic fibrosis, who are taking other medications and might be at risk of dangerous drug interactions, or who have a family history of psychosis.

Jenkins emphasizes that cannabis use is not “safe.” Even if it doesn’t land most users in the hospital, it comes with very real risks, including addiction. However, when she encounters a patient using cannabis heavily, she does what she can to help them make their use safer. “If I told them you can’t use marijuana, they’d say, ‘see you later,’ which isn’t what I want,” she says. “So even though I would hope they would get to a place where they didn’t need to use marijuana, I work with them where they’re at.”

A new drug appears to slow Alzheimer’s. Here’s what to know

Tampa Bay Times, St. Petersburg, Fla

A new drug appears to slow Alzheimer’s. Here’s what to know

Hannah Critchfield, Tampa Bay Times – December 5, 2022

An experimental drug appears to slow cognitive decline in people with early onset Alzheimer’s.

New data on lecanemab, which is manufactured by Biogen and Esai, was published last week in the New England Journal of Medicine that showed people who took the drug experienced “moderately less decline on measures of cognition and function.”

However, some patients also experienced negative side effects like brain swelling and bleeding — meaning people with early Alzheimer’s disease should be aware of the risks before seeking treatment.

How does it work?

Lecanemab decreases the amount of amyloid plaque in the brain. The protein deposits have long been hypothesized to be linked to the progression of Alzheimer’s.

The theory goes like this: Decrease the plaque and you’ll slow the effects of the memory disease.

The new data on lecanemab provides the strongest support for that theory to date.

“That is huge because it gives the person living with the disease an opportunity to be able to live at a higher level of functioning in their life,” said Keith Gibson, director of diversity, equity and inclusion at the Florida Alzheimer’s Association. “It gives them a greater chance to be as normal as possible before the disease really runs its full course. We’re very, very excited about that.”

The 18-month study, which was funded by its manufacturers and involved people aged 50 to 90 with early Alzheimer’s, nevertheless concluded by noting that “longer trials are warranted to determine the efficacy and safety of lecanemab in early Alzheimer’s disease.”

Who can take it?

The drug is intended for people with early-onset Alzheimer’s or mild cognitive impairment.

People who have more advanced stages of Alzheimer’s will likely not be eligible for the treatment.

Given the negative side effects experienced by some patients involved in the study, patients should speak with their doctors when considering whether to seek out lecanemab.

Can I get it now?

People interested in the drug might not have to wait long.

The Food and Drug Administration is considering lecanemab for accelerated approval, and will make its decision on Jan. 6.

How much will it cost?

Esai has said lecanemab could cost between $9,249 and $35,605 a year, a broad estimate that has yet to be narrowed down.

It’s unclear if the drug will be covered by the Centers for Medicare & Medicaid Services should it receive accelerated approval.

Currently, based on an agency decision made in April, Medicare and Medicaid has said it generally will not pay for Alzheimer’s treatments aimed at attacking amyloid plaque until they receive full approval by the Food and Drug Administration, except in clinical trial settings.

A spokesperson for Medicare and Medicaid said it is reviewing the publication in the New England Journal of Medicine and “has met with manufacturers to learn about their efforts” since the April criteria decision.

What if I’m already on another drug that attempts to slow Alzheimer’s?

There’s currently only one drug on the market that attempts to slow progression of Alzheimer’s by reducing the level of plaque in the brain.

Known as Aduhelm or aducanamab, the controversial treatment received federal approval last year, despite limited results that the drug helped patients.

It’s currently unclear how doctors will advise the limited number of patients who are already receiving Aduhelm treatments and want to switch over to lecanemab, which appears to have more conclusive data about its efficacy.

People who are currently taking Aduhelm and are interested in lecanemab should speak to their physicians about next steps.

Shorter days affect the mood of millions of Americans – a nutritional neuroscientist offers tips on how to avoid the winter blues

The Conversation

Shorter days affect the mood of millions of Americans – a nutritional neuroscientist offers tips on how to avoid the winter blues

Lina Begdache, Associate Professor of Health and Wellness Studies, Binghamton University, State University of New York

December 5, 2022

For those prone to seasonal affective disorder, a shift in the sleep cycle can impact energy levels. <a href=
For those prone to seasonal affective disorder, a shift in the sleep cycle can impact energy levels. Ben Akiba/E+ via Getty Images

The annual pattern of winter depression and melancholy – better known as seasonal affective disorder, or SAD – suggests a strong link between your mood and the amount of light you get during the day.

To put it simply: The less light exposure one has, the more one’s mood may decline.

Wintertime blues are common, but about 10 million Americans are affected every year by a longer lasting depression called seasonal affective disorder. Along with low mood, symptoms include anxious feelings, low self-esteem, longer sleep duration, constant craving for carbohydrates and low physical activity levels.

I am a nutritional neuroscientist, and my research focuses on the effects of diet and lifestyle factors on mood and brain functions such as mental distress, resilience and motivation.

Through my research, I have learned that seasonal affective disorder can strike anyone. However, people with a history of mood disorders are at a higher risk. In particular, young adults and women of all ages have an increased susceptibility.

Why seasonal depression happens

When daylight saving time ends each fall, the one-hour shift backward reduces the amount of light exposure most people receive in a 24-hour cycle. As the days get shorter, people can experience general moodiness or a longer-term depression that is tied to a shorter exposure to daylight.

This happens due to a misalignment between the sleep-wake cycle, eating schedules and other daily tasks. Research shows that this mismatch may be associated with poor mental health outcomes, such as anxiety and depression.

Our sleep-wake cycle is controlled by the circadian rhythm, an internal clock regulated by light and darkness. Like a regular clock, it resets nearly every 24 hours and controls metabolism, growth and hormone release.

When our brain receives signals of limited daylight, it releases the hormone melatonin to support sleep – even though we still have hours left before the typical bedtime. This can then affect how much energy we have, and when and how much we eat. It can also alter the brain’s ability to adapt to changes in environment. This process, called neuronal plasticity, involves the growth and organization of neural networks. This is crucial for brain repair, maintenance and overall function.

It is possible to readjust the circadian rhythm to better align with the new light and dark schedule. This means getting daylight exposure as soon as possible upon waking up, as well as maintaining sleep, exercise and eating routines that are more in sync with your routine prior to the time change. Eventually, people can gradually transition into the new schedule.

The intimate connection between serotonin and melatonin

Serotonin is a chemical messenger in the brain that is a key player in regulating several functions such as mood, appetite and the circadian rhythm. Serotonin also converts to melatonin with lower light intensity. As mentioned above, melatonin is a hormone that regulates the sleep-wake cycle and signals the brain that it’s time to sleep.

Less daylight exposure during winter months leads to the conversion of serotonin into melatonin earlier in the evening, since it gets dark earlier. As a result, this untimely melatonin release causes a disruption in the sleep-wake cycle. For some people this can cause moodiness, daytime sleepiness and loss of appetite regulation, typically leading to unhealthy snacking. People with seasonal affective disorder often crave foods rich in simple sugars, such as sweets, because there is an intimate connection between carbohydrate consumption, appetite regulation and sleep.

Strategies to combat the winter blues

In winter, most people leave work when it’s turning dark. For this reason, light therapy is typically recommended for those who experience seasonal affective disorder, or even shorter periods of seasonal funk.

This can be as simple as getting some light shortly after awakening. Try to get at least one hour of natural light during the early morning hours, preferably about one hour after your usual morning wake-up time when the circadian clock is most sensitive to light. This is true no matter what your wake-up time is, as long as it’s morning. For people living at northern latitudes where there’s very little sun in winter, light therapy boxes – which replicate outdoor light – can be effective.

You can also improve your sleep quality by avoiding stimulants like coffee, tea or heavy meals close to bedtime. Exercising during the day is also good – it increases serotonin production and supports circadian regulation. A balanced diet of complex carbs and healthy proteins supports steady serotonin and melatonin production, and practicing downtime before bed can reduce stress.

Taking these small steps may help the circadian rhythm adjust faster. For the millions with mood disorders, that could mean happier times during what are literally the darkest days.

Lina Begdache does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.